Report Detail

Pharma & Healthcare Global and United States Oncology (Anti-cancer Drugs) Market Size, Status and Forecast 2020-2026

  • RnM4121103
  • |
  • 16 September, 2020
  • |
  • Global
  • |
  • 91 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Oncology (Anti-cancer Drugs) Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Blood Cancer
    • 1.2.3 Breast Cancer
    • 1.2.4 Gastrointestinal Cancer
    • 1.2.5 Prostate Cancer
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Oncology (Anti-cancer Drugs) Market Share by Application: 2020 VS 2026
    • 1.3.2 Chemotherapy
    • 1.3.3 Targeted Therapy
    • 1.3.4 Immunotherapy (Biologic Therapy)
    • 1.3.5 Hormonal Therapy
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Oncology (Anti-cancer Drugs) Market Perspective (2015-2026)
  • 2.2 Global Oncology (Anti-cancer Drugs) Growth Trends by Regions
    • 2.2.1 Oncology (Anti-cancer Drugs) Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Oncology (Anti-cancer Drugs) Historic Market Share by Regions (2015-2020)
    • 2.2.3 Oncology (Anti-cancer Drugs) Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Oncology (Anti-cancer Drugs) Players by Market Size
    • 3.1.1 Global Top Oncology (Anti-cancer Drugs) Players by Revenue (2015-2020)
    • 3.1.2 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Players (2015-2020)
  • 3.2 Global Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Oncology (Anti-cancer Drugs) Revenue
  • 3.4 Global Oncology (Anti-cancer Drugs) Market Concentration Ratio
    • 3.4.1 Global Oncology (Anti-cancer Drugs) Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Oncology (Anti-cancer Drugs) Revenue in 2019
  • 3.5 Key Players Oncology (Anti-cancer Drugs) Area Served
  • 3.6 Key Players Oncology (Anti-cancer Drugs) Product Solution and Service
  • 3.7 Date of Enter into Oncology (Anti-cancer Drugs) Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology (Anti-cancer Drugs) Breakdown Data by Type (2015-2026)

  • 4.1 Global Oncology (Anti-cancer Drugs) Historic Market Size by Type (2015-2020)
  • 4.2 Global Oncology (Anti-cancer Drugs) Forecasted Market Size by Type (2021-2026)

5 Oncology (Anti-cancer Drugs) Breakdown Data by Application (2015-2026)

  • 5.1 Global Oncology (Anti-cancer Drugs) Historic Market Size by Application (2015-2020)
  • 5.2 Global Oncology (Anti-cancer Drugs) Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Oncology (Anti-cancer Drugs) Market Size (2015-2026)
  • 6.2 North America Oncology (Anti-cancer Drugs) Market Size by Type (2015-2020)
  • 6.3 North America Oncology (Anti-cancer Drugs) Market Size by Application (2015-2020)
  • 6.4 North America Oncology (Anti-cancer Drugs) Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Oncology (Anti-cancer Drugs) Market Size (2015-2026)
  • 7.2 Europe Oncology (Anti-cancer Drugs) Market Size by Type (2015-2020)
  • 7.3 Europe Oncology (Anti-cancer Drugs) Market Size by Application (2015-2020)
  • 7.4 Europe Oncology (Anti-cancer Drugs) Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Oncology (Anti-cancer Drugs) Market Size (2015-2026)
  • 8.2 China Oncology (Anti-cancer Drugs) Market Size by Type (2015-2020)
  • 8.3 China Oncology (Anti-cancer Drugs) Market Size by Application (2015-2020)
  • 8.4 China Oncology (Anti-cancer Drugs) Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Oncology (Anti-cancer Drugs) Market Size (2015-2026)
  • 9.2 Japan Oncology (Anti-cancer Drugs) Market Size by Type (2015-2020)
  • 9.3 Japan Oncology (Anti-cancer Drugs) Market Size by Application (2015-2020)
  • 9.4 Japan Oncology (Anti-cancer Drugs) Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

.4 Oncology (Anti-cancer Drugs) Market Size by Country (2015-2020)

  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

10 Key Players Profiles

  • 10.1 Roche
    • 10.1.1 Roche Company Details
    • 10.1.2 Roche Business Overview
    • 10.1.3 Roche Oncology (Anti-cancer Drugs) Introduction
    • 10.1.4 Roche Revenue in Oncology (Anti-cancer Drugs) Business (2015-2020))
    • 10.1.5 Roche Recent Development
  • 10.2 Novartis
    • 10.2.1 Novartis Company Details
    • 10.2.2 Novartis Business Overview
    • 10.2.3 Novartis Oncology (Anti-cancer Drugs) Introduction
    • 10.2.4 Novartis Revenue in Oncology (Anti-cancer Drugs) Business (2015-2020)
    • 10.2.5 Novartis Recent Development
  • 10.3 Celgene
    • 10.3.1 Celgene Company Details
    • 10.3.2 Celgene Business Overview
    • 10.3.3 Celgene Oncology (Anti-cancer Drugs) Introduction
    • 10.3.4 Celgene Revenue in Oncology (Anti-cancer Drugs) Business (2015-2020)
    • 10.3.5 Celgene Recent Development
  • 10.4 Amgen
    • 10.4.1 Amgen Company Details
    • 10.4.2 Amgen Business Overview
    • 10.4.3 Amgen Oncology (Anti-cancer Drugs) Introduction
    • 10.4.4 Amgen Revenue in Oncology (Anti-cancer Drugs) Business (2015-2020)
    • 10.4.5 Amgen Recent Development
  • 10.5 Johnson & Johnson
    • 10.5.1 Johnson & Johnson Company Details
    • 10.5.2 Johnson & Johnson Business Overview
    • 10.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Introduction
    • 10.5.4 Johnson & Johnson Revenue in Oncology (Anti-cancer Drugs) Business (2015-2020)
    • 10.5.5 Johnson & Johnson Recent Development
  • 10.6 GlaxoSmithKline
    • 10.6.1 GlaxoSmithKline Company Details
    • 10.6.2 GlaxoSmithKline Business Overview
    • 10.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Introduction
    • 10.6.4 GlaxoSmithKline Revenue in Oncology (Anti-cancer Drugs) Business (2015-2020)
    • 10.6.5 GlaxoSmithKline Recent Development
  • 10.7 Eli lilly & Co
    • 10.7.1 Eli lilly & Co Company Details
    • 10.7.2 Eli lilly & Co Business Overview
    • 10.7.3 Eli lilly & Co Oncology (Anti-cancer Drugs) Introduction
    • 10.7.4 Eli lilly & Co Revenue in Oncology (Anti-cancer Drugs) Business (2015-2020)
    • 10.7.5 Eli lilly & Co Recent Development
  • 10.8 Pfizer
    • 10.8.1 Pfizer Company Details
    • 10.8.2 Pfizer Business Overview
    • 10.8.3 Pfizer Oncology (Anti-cancer Drugs) Introduction
    • 10.8.4 Pfizer Revenue in Oncology (Anti-cancer Drugs) Business (2015-2020)
    • 10.8.5 Pfizer Recent Development
  • 10.9 Merck & Co.
    • 10.9.1 Merck & Co. Company Details
    • 10.9.2 Merck & Co. Business Overview
    • 10.9.3 Merck & Co. Oncology (Anti-cancer Drugs) Introduction
    • 10.9.4 Merck & Co. Revenue in Oncology (Anti-cancer Drugs) Business (2015-2020)
    • 10.9.5 Merck & Co. Recent Development
  • 10.10 Sanofi
    • 10.10.1 Sanofi Company Details
    • 10.10.2 Sanofi Business Overview
    • 10.10.3 Sanofi Oncology (Anti-cancer Drugs) Introduction
    • 10.10.4 Sanofi Revenue in Oncology (Anti-cancer Drugs) Business (2015-2020)
    • 10.10.5 Sanofi Recent Development

11 Analyst's Viewpoints/Conclusions

    12 Appendix

    • 12.1 Research Methodology
      • 12.1.1 Methodology/Research Approach
      • 12.1.2 Data Source
    • 12.2 Disclaimer

    Global Oncology (Anti-cancer Drugs) Scope and Market Size
    Oncology (Anti-cancer Drugs) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncology (Anti-cancer Drugs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Blood Cancer
    Breast Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Others

    Market segment by Application, split into
    Chemotherapy
    Targeted Therapy
    Immunotherapy (Biologic Therapy)
    Hormonal Therapy
    Others

    Based on regional and country-level analysis, the Oncology (Anti-cancer Drugs) market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Oncology (Anti-cancer Drugs) market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Roche
    Novartis
    Celgene
    Amgen
    Johnson & Johnson
    GlaxoSmithKline
    Eli lilly & Co
    Pfizer
    Merck & Co.
    Sanofi


    Summary:
    Get latest Market Research Reports on Oncology (Anti-cancer Drugs). Industry analysis & Market Report on Oncology (Anti-cancer Drugs) is a syndicated market report, published as Global and United States Oncology (Anti-cancer Drugs) Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Oncology (Anti-cancer Drugs) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,011.26
    4,516.88
    6,022.51
    3,342.80
    5,014.19
    6,685.59
    407,936.10
    611,904.15
    815,872.20
    290,273.88
    435,410.82
    580,547.76
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report